6 assets in Chronic Rhinosinusitis

Therapeutic assets addressing Chronic Rhinosinusitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Methoxiflurane Chronic Rhinosinusitis	St. Paul's Hospital, Canada	P1/2	CCC (48)
Jnj-54135419 Chronic Rhinosinusitis	The Second People's Hospital of Huai'an	P1/2	CC (47)
Lavender Oil Chronic Rhinosinusitis	Cedars-Sinai Medical Center	N/A	D (30)